FR16C0033I2 - Methode de formation de composes d'hydroxypyrone de fer - Google Patents
Methode de formation de composes d'hydroxypyrone de ferInfo
- Publication number
- FR16C0033I2 FR16C0033I2 FR16C0033C FR16C0033C FR16C0033I2 FR 16C0033 I2 FR16C0033 I2 FR 16C0033I2 FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 I2 FR16C0033 I2 FR 16C0033I2
- Authority
- FR
- France
- Prior art keywords
- formation
- iron hydroxypyrone
- hydroxypyrone compounds
- iron
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QQTUBEKQMMRXHC-UHFFFAOYSA-N 3-hydroxypyran-2-one;iron Chemical class [Fe].OC1=CC=COC1=O QQTUBEKQMMRXHC-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- LIPRKYKMVQPYPG-UHFFFAOYSA-N 3-Hydroxy-2H-pyran-2-one Chemical compound OC1=CC=COC1=O LIPRKYKMVQPYPG-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 150000002505 iron Chemical class 0.000 abstract 1
- -1 iron hydroxypyrone compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Iron (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0211500.4A GB0211500D0 (en) | 2002-05-18 | 2002-05-18 | Method of forming iron hydroxypyrone compounds |
| PCT/GB2003/001956 WO2003097627A1 (en) | 2002-05-18 | 2003-05-07 | Method of forming iron hydroxypyrone compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR16C0033I1 FR16C0033I1 (cs) | 2016-09-23 |
| FR16C0033I2 true FR16C0033I2 (fr) | 2018-01-19 |
Family
ID=9936987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR16C0033C Active FR16C0033I2 (fr) | 2002-05-18 | 2016-08-09 | Methode de formation de composes d'hydroxypyrone de fer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7459569B2 (cs) |
| EP (1) | EP1506183B1 (cs) |
| AT (1) | ATE352547T1 (cs) |
| AU (1) | AU2003233881A1 (cs) |
| BE (1) | BE2016C041I2 (cs) |
| CA (1) | CA2483067C (cs) |
| DE (1) | DE60311456T2 (cs) |
| ES (1) | ES2283771T3 (cs) |
| FR (1) | FR16C0033I2 (cs) |
| GB (1) | GB0211500D0 (cs) |
| WO (1) | WO2003097627A1 (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8952061B2 (en) * | 2006-08-22 | 2015-02-10 | University Of Virginia Patent Foundation | Methods and compounds regulating the erythroid response to iron deficiency |
| GB2451713B (en) | 2007-02-06 | 2009-12-16 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
| GB0808835D0 (en) | 2008-05-15 | 2008-06-18 | Vitra Pharmaceuticals Ltd | Therapeutic compositions |
| US8536106B2 (en) | 2010-04-14 | 2013-09-17 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
| GB201101370D0 (en) * | 2011-01-27 | 2011-03-09 | Iron Therapeutics Holdings Ag | Process |
| GB201404390D0 (en) * | 2014-03-12 | 2014-04-23 | Iron Therapeutics Holdings Ag | Composition |
| EP3157516A4 (en) | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| GB2531742B (en) * | 2014-10-28 | 2016-10-05 | Iron Therapeutics Holdings Ag | Polymorphs of ferric maltol |
| GB201517893D0 (en) | 2015-10-09 | 2015-11-25 | Medical Res Council | Methods for producing carboxylate ligand modified ferric iron hydroxide colloids |
| AU2017242906B2 (en) * | 2016-03-31 | 2020-11-19 | Shield TX (UK) Limited | Methods for producing Ferric maltol compositions from Ferrous Hydroxides |
| CN109790138B (zh) * | 2016-03-31 | 2023-08-18 | 英国神盾Tx股份有限公司 | 由配体修饰的和配体涂覆的氢氧化铁生产麦芽酚铁组合物的方法 |
| US11155529B2 (en) | 2016-03-31 | 2021-10-26 | Shield TX (UK) Limited | Methods for producing ferric maltol compositions from elemental iron |
| EA201892194A1 (ru) | 2016-03-31 | 2019-04-30 | Юнайтед Киндом Рисёрч Энд Инновейшн | Композиции комплекса трехвалентного железа с мальтолом для применения для лечения или предотвращения рака и опухолей |
| GB202005054D0 (en) | 2020-04-06 | 2020-05-20 | Nemysis Ltd | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases |
| CN112574158B (zh) * | 2020-12-29 | 2022-08-02 | 南京百泽医药科技有限公司 | 一种麦芽酚铁晶型ii及其制备方法 |
| CN115177625A (zh) * | 2022-06-28 | 2022-10-14 | 金陵药业股份有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3130204A (en) | 1962-02-07 | 1964-04-21 | Pfizer & Co C | Preparation of gamma-pyrones |
| DE1518098A1 (de) | 1963-09-19 | 1969-04-10 | Pfizer & Co C | Verfahren zur Herstellung von Pyromekonsaeurederivaten |
| SE322866B (cs) | 1966-12-15 | 1970-04-20 | Astra Ab | |
| US4018907A (en) | 1975-08-25 | 1977-04-19 | General Foods Corporation | Coloring food with iron-complexes |
| US4212685A (en) * | 1978-12-11 | 1980-07-15 | Lea Manufacturing Company | Protective and color receptive coating for aluminum |
| US4279936A (en) | 1979-09-24 | 1981-07-21 | William Underwood Company | Maltol treated canned meat process |
| GR78491B (cs) | 1982-03-24 | 1984-09-27 | Nat Res Dev | |
| EP0094149B1 (en) | 1982-03-24 | 1986-09-10 | National Research Development Corporation | Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives |
| EP0107458B1 (en) | 1982-10-22 | 1987-07-29 | National Research Development Corporation | Pharmaceutical compositions |
| GB8308055D0 (en) | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308054D0 (en) | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8325494D0 (en) | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| US4912118A (en) | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
| USRE34313E (en) | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
| GB8325496D0 (en) | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| GB8329043D0 (en) | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
| GB8410290D0 (en) * | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
| US5177068A (en) | 1984-04-19 | 1993-01-05 | National Research Development Corporation | Pharmaceutical compositions |
| GB8410289D0 (en) | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
| GB8606913D0 (en) | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
| JPH0367565A (ja) | 1989-08-07 | 1991-03-22 | Kansai Paint Co Ltd | 鉄分強化食品 |
| GB9209078D0 (en) | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
| GB9217099D0 (en) | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| ATE273702T1 (de) * | 1995-06-10 | 2004-09-15 | Vitra Pharmaceuticals Ltd | Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
-
2002
- 2002-05-18 GB GBGB0211500.4A patent/GB0211500D0/en not_active Ceased
-
2003
- 2003-05-07 EP EP03727643A patent/EP1506183B1/en not_active Expired - Lifetime
- 2003-05-07 WO PCT/GB2003/001956 patent/WO2003097627A1/en active Search and Examination
- 2003-05-07 ES ES03727643T patent/ES2283771T3/es not_active Expired - Lifetime
- 2003-05-07 AU AU2003233881A patent/AU2003233881A1/en not_active Abandoned
- 2003-05-07 US US10/514,836 patent/US7459569B2/en not_active Expired - Lifetime
- 2003-05-07 AT AT03727643T patent/ATE352547T1/de not_active IP Right Cessation
- 2003-05-07 DE DE60311456T patent/DE60311456T2/de not_active Expired - Lifetime
- 2003-05-07 CA CA2483067A patent/CA2483067C/en not_active Expired - Lifetime
-
2016
- 2016-08-09 FR FR16C0033C patent/FR16C0033I2/fr active Active
- 2016-08-17 BE BE2016C041C patent/BE2016C041I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2483067A1 (en) | 2003-11-27 |
| US7459569B2 (en) | 2008-12-02 |
| DE60311456D1 (de) | 2007-03-15 |
| EP1506183B1 (en) | 2007-01-24 |
| FR16C0033I1 (cs) | 2016-09-23 |
| GB0211500D0 (en) | 2002-06-26 |
| WO2003097627A1 (en) | 2003-11-27 |
| ES2283771T3 (es) | 2007-11-01 |
| ATE352547T1 (de) | 2007-02-15 |
| CA2483067C (en) | 2011-04-26 |
| AU2003233881A1 (en) | 2003-12-02 |
| US20050250754A1 (en) | 2005-11-10 |
| EP1506183A1 (en) | 2005-02-16 |
| BE2016C041I2 (cs) | 2022-08-09 |
| DE60311456T2 (de) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR16C0033I2 (fr) | Methode de formation de composes d'hydroxypyrone de fer | |
| CY1108593T1 (el) | Συμπυκνωμενο υδατικο διαλυμα αμβροξολης | |
| MXPA03000510A (es) | Sales estables de acido o-acetilsalicilico con aminoacidos basicos. | |
| TW200504058A (en) | Method for preparing fused oxazinones | |
| TR199902759T2 (xx) | Sertindole �retimi i�in bir y�ntem | |
| TR200100016T2 (tr) | Hidroksimetiltiobütirik asitin hazırlanmasına yönelik metod | |
| WO2004095921A3 (en) | Sporicidal composition | |
| PL365213A1 (en) | Enteric ketoacid salts and amino acids | |
| WO2002024001A3 (de) | Tierfuttersupplement enthaltend d-pantothensäure und/oder deren salze, verbessertes verfahren zu dessen herstellung sowie dessen verwendung | |
| HRP20031004A2 (en) | Method for producing an essentially chlorite-free,stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same | |
| AU2002250978A1 (en) | Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed | |
| NO20001070D0 (no) | Diureider og deres anvendelse | |
| WO2003035636A3 (en) | Process for the preparation of 3 - isochromanone | |
| IT1291673B1 (it) | Processo per la preparazione di 1,4,7,10 - tetraazaciclododecano | |
| EA200200783A2 (ru) | Почвоулучшитель и средство для витализации воды | |
| ATE374764T1 (de) | Basisches salz von thiooctansäure mitl-carnitin | |
| AU2001249606A1 (en) | Method of cyanide salt production | |
| WO2003051297A3 (en) | Aqueous ifosfamide composition | |
| EP1291019A4 (en) | BIOLOGICALLY ACTIVE AGENTS AND DRUGS | |
| RU2000109795A (ru) | Способ получения магнитоактивного соединения | |
| FR2816954B1 (fr) | Solution aqueuse boree, realiser a partir d'un compose d'acide borique et de carbonate de sodium | |
| MY134147A (en) | Method for stoping hysteresis | |
| EP1245535A3 (en) | An aqueous solution containing hydroxylamine salt and storing method thereof | |
| PL369502A1 (en) | Salts of substituted 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid derivatives | |
| MXPA04000513A (es) | Proceso para la preparacion de 4-metilamino-4-fenilpiperidina. |